COVID-19 Diagnostics Dashboards
Interactive tools to support product selection and procurement decisions by aggregating and visualizing publicly available information about the development, supply, regulatory approvals, and performance of COVID-19 diagnostic tests
Large-scale testing and contact tracing are central to efforts to control the COVID-19 pandemic. This relies on diagnostic tests that can rapidly, accurately, and reliably detect SARS-CoV-2. However, with over 1,000 COVID diagnostics tests currently in development or on the market, understanding test quality, performance, and availability at the global and country level is extremely challenging.
Explore other COVID-19 dashboards:
- Global availability of COVID-19 diagnostic tests
- Regulatory authorizations by country for COVID-19 diagnostic tests
- COVID-19 antigen diagnostic test pipeline
- Implications of variants on antigen test detection
- Implications of variants on molecular test detection
- COVID-19 diagnostics procurement resource
- COVID-19 self-test dashboard
About this resource
A multidisciplinary team at PATH has developed the interactive COVID-19 Diagnostics Dashboard which consolidates publicly available market intelligence to support data-driven procurement and purchasing decisions. This tool is designed to be used by national governments, procurers, funders, and policymakers.
Diagnostics can be searched by diagnostic platform, test performance, regulatory status, country of origin, and commercial availability.
This project is currently being funded by The Access Delivery Partnership.
To be notified about updates to these dashboards please email dxcovid@path.org.
Manufacturers are encouraged to email links of publicly available confirmatory lab data that demonstrates their assays work with variants to dxcovid@path.org.
Learn more about PATH's diagnostics program.
